Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus

NCT00774800 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Humalog
DRUG: Humulin-R
DRUG: Recombinant human hyaluronidase PH20 (rHuPH20)
OTHER: Liquid meal

Sponsor

Halozyme Therapeutics